UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Management of NAFLD patients with advanced fibrosis

Liver international, 2021-06, Vol.41 (S1), p.95-104

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel insights into metabolic‐associated steatotic liver disease preclinical models

Liver international, 2024-03, Vol.44 (3), p.644-662

2024

Link zum Volltext

Verfügbarkeit prüfen

High levels of histones promote whole-genome-duplications and trigger a Swe1WEE1-dependent phosphorylation of Cdc28CDK1

eLife, 2018-03, Vol.7

2018

Link zum Volltext

Verfügbarkeit prüfen

Histone stress: an unexplored source of chromosomal instability in cancer?

Current genetics, 2019-10, Vol.65 (5), p.1081-1088

2019

Link zum Volltext

Verfügbarkeit prüfen

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

Journal of gastroenterology, 2022-05, Vol.57 (5), p.357-371

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcription and FACT facilitate the restoration of replication-coupled chromatin assembly defects

Scientific reports, 2023-07, Vol.13 (1), p.11397-11397, Article 11397

2023

Link zum Volltext

Verfügbarkeit prüfen

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

Liver international, 2022-06, Vol.42 (6), p.1410-1422

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11840

2022

Link zum Volltext

Verfügbarkeit prüfen

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver

Frontiers in endocrinology (Lausanne), 2022-05, Vol.13, p.892672-892672

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

Frontiers in immunology, 2021-11, Vol.12, p.667354-667354

2021

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between chromatin structure, cohesin activity and transcription

Epigenetics & chromatin, 2019-07, Vol.12 (1), p.47-47, Article 47

2019

Link zum Volltext

Verfügbarkeit prüfen

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System

Journal of personalized medicine, 2021-05, Vol.11 (6), p.475

2021

Link zum Volltext

Verfügbarkeit prüfen

Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)

Journal of hepatology, 2023-06, Vol.78, p.S760-S761

2023

Link zum Volltext

Verfügbarkeit prüfen

WED-440 - Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)

Journal of hepatology, 2023-06, Vol.78, p.S760-S761

2023

Link zum Volltext

Verfügbarkeit prüfen

MASLD biomarkers: Are we facing a new era?

Gastroenterología y Hepatología (English Edition), 2024-04, Vol.47 (4), p.393-396

2024

Link zum Volltext

Verfügbarkeit prüfen

P18 Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase

The American journal of gastroenterology, 2023-09, Vol.118 (9S), p.S13-S13

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT014 - Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

Journal of hepatology, 2020-08, Vol.73, p.S660-S660

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

Journal of hepatology, 2020-08, Vol.73, p.S660

2020

Link zum Volltext

Verfügbarkeit prüfen

MASLD biomarkers: Are we facing a new era?

Gastroenterología y hepatología, 2024-04, Vol.47 (4), p.393-396

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis

Revista española de enfermedades digestivas, 2021-02, Vol.113 (2), p.125-135

2021

Link zum Volltext

Verfügbarkeit prüfen

FRI-299-Transcriptomic and epigenetic characterization of a NAFLD murine model

Journal of hepatology, 2019-04, Vol.70 (1), p.e526-e527

2019

Link zum Volltext

Verfügbarkeit prüfen

Coordination of Cell Cycle Progression and Mitotic Spindle Assembly Involves Histone H3 Lysine 4 Methylation by Set1/COMPASS

Genetics (Austin), 2017-01, Vol.205 (1), p.185-199

2017

Link zum Volltext

Verfügbarkeit prüfen

SAT-250-Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study

Journal of hepatology, 2019-04, Vol.70 (1), p.e742-e743

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Management of NAFLD patients with advanced fibrosis

Novel insights into metabolic‐associated steatotic liver disease preclinical models

High levels of histones promote whole-genome-duplications and trigger a Swe1WEE1-dependent phosphorylation of Cdc28CDK1

Histone stress: an unexplored source of chromosomal instability in cancer?

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

Transcription and FACT facilitate the restoration of replication-coupled chromatin assembly defects

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

Crosstalk between chromatin structure, cohesin activity and transcription

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System

Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)

WED-440 - Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)

MASLD biomarkers: Are we facing a new era?

P18 Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase

SAT014 - Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

MASLD biomarkers: Are we facing a new era?

Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis

FRI-299-Transcriptomic and epigenetic characterization of a NAFLD murine model

The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

Coordination of Cell Cycle Progression and Mitotic Spindle Assembly Involves Histone H3 Lysine 4 Methylation by Set1/COMPASS

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

SAT-250-Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study

Suchergebnisse filtern